Cargando…

Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid

Ionic liquids (ILs) have been proven to be an efficient technology for enhancing drug skin permeability. However, the question of whether the two components of ILs are released synchronously in transdermal preparations has remained unclear. Thus, this study aimed to investigate the release character...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Degong, Chen, Xuejun, Li, Ziqing, Yang, Chunrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610533/
https://www.ncbi.nlm.nih.gov/pubmed/36297593
http://dx.doi.org/10.3390/pharmaceutics14102158
_version_ 1784819293684236288
author Yang, Degong
Chen, Xuejun
Li, Ziqing
Yang, Chunrong
author_facet Yang, Degong
Chen, Xuejun
Li, Ziqing
Yang, Chunrong
author_sort Yang, Degong
collection PubMed
description Ionic liquids (ILs) have been proven to be an efficient technology for enhancing drug skin permeability. However, the question of whether the two components of ILs are released synchronously in transdermal preparations has remained unclear. Thus, this study aimed to investigate the release characteristics of two components of ILs and their underlying molecular mechanism. The ILs containing flurbiprofen (FLU) and lidocaine (LID) were synthesized and characterized. The four typical acrylates pressure sensitive adhesives (PSAs) with different functional groups were synthesized and characterized. The effects of PSAs on the release characteristics of two components of ILs were investigated by drug release tests and verified by skin permeation experiments. The action mechanisms were revealed by FTIR, Raman, dielectric spectrum, and molecular docking. The results showed that the average release amount of FLU (0.29 μmol/cm(2)) and LID (0.11 μmol/cm(2)) of ILs in the four PSAs was significantly different (p < 0.05), which illustrated that the two components did not release synchronously. The PSA−none and PSA−OH with low permittivity (7.37, 9.82) interacted with drugs mainly by dipole-dipole interactions and hydrogen bonds. The PSA−COOH and PSA−CONH(2) with high permittivity (11.19, 15.32) interacted with drugs mainly by ionic bonds and ionic hydrogen bonds. Thus, this study provides scientific guidance for the application of ILs in transdermal preparations.
format Online
Article
Text
id pubmed-9610533
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96105332022-10-28 Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid Yang, Degong Chen, Xuejun Li, Ziqing Yang, Chunrong Pharmaceutics Article Ionic liquids (ILs) have been proven to be an efficient technology for enhancing drug skin permeability. However, the question of whether the two components of ILs are released synchronously in transdermal preparations has remained unclear. Thus, this study aimed to investigate the release characteristics of two components of ILs and their underlying molecular mechanism. The ILs containing flurbiprofen (FLU) and lidocaine (LID) were synthesized and characterized. The four typical acrylates pressure sensitive adhesives (PSAs) with different functional groups were synthesized and characterized. The effects of PSAs on the release characteristics of two components of ILs were investigated by drug release tests and verified by skin permeation experiments. The action mechanisms were revealed by FTIR, Raman, dielectric spectrum, and molecular docking. The results showed that the average release amount of FLU (0.29 μmol/cm(2)) and LID (0.11 μmol/cm(2)) of ILs in the four PSAs was significantly different (p < 0.05), which illustrated that the two components did not release synchronously. The PSA−none and PSA−OH with low permittivity (7.37, 9.82) interacted with drugs mainly by dipole-dipole interactions and hydrogen bonds. The PSA−COOH and PSA−CONH(2) with high permittivity (11.19, 15.32) interacted with drugs mainly by ionic bonds and ionic hydrogen bonds. Thus, this study provides scientific guidance for the application of ILs in transdermal preparations. MDPI 2022-10-10 /pmc/articles/PMC9610533/ /pubmed/36297593 http://dx.doi.org/10.3390/pharmaceutics14102158 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Degong
Chen, Xuejun
Li, Ziqing
Yang, Chunrong
Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title_full Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title_fullStr Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title_full_unstemmed Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title_short Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
title_sort mechanistic study of release characteristics of two active ingredients in transdermal patch containing lidocaine−flurbiprofen ionic liquid
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610533/
https://www.ncbi.nlm.nih.gov/pubmed/36297593
http://dx.doi.org/10.3390/pharmaceutics14102158
work_keys_str_mv AT yangdegong mechanisticstudyofreleasecharacteristicsoftwoactiveingredientsintransdermalpatchcontaininglidocaineflurbiprofenionicliquid
AT chenxuejun mechanisticstudyofreleasecharacteristicsoftwoactiveingredientsintransdermalpatchcontaininglidocaineflurbiprofenionicliquid
AT liziqing mechanisticstudyofreleasecharacteristicsoftwoactiveingredientsintransdermalpatchcontaininglidocaineflurbiprofenionicliquid
AT yangchunrong mechanisticstudyofreleasecharacteristicsoftwoactiveingredientsintransdermalpatchcontaininglidocaineflurbiprofenionicliquid